Literature DB >> 28826628

Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy.

Matthew J Ferris1, Jim Zhong2, Jeffrey M Switchenko3, Kristin A Higgins2, Richard J Cassidy2, Mark W McDonald2, Bree R Eaton2, Kirtesh R Patel2, Conor E Steuer4, H Michael Baddour5, Andrew H Miller6, Deborah W Bruner7, Canhua Xiao8, Jonathan J Beitler2.   

Abstract

BACKGROUND AND
PURPOSE: Radiation (RT) dose to the central nervous system (CNS) has been implicated as a contributor to treatment-related fatigue in head and neck cancer (HNC) patients undergoing radiation therapy (RT). This study evaluates the association of RT dose to CNS structures with patient-reported (PRO) fatigue scores in a population of HNC patients.
MATERIALS AND METHODS: At pre-RT (baseline), 6th week of RT, and 1-month post-RT time points, Multidimensional Fatigue Inventory (MFI-20) scores were prospectively obtained from 124 patients undergoing definitive treatment for HNC. Medulla, pons, midbrain, total brainstem, cerebellum, posterior fossa, and pituitary dosimetry were evaluated using summary statistics and dose-volume histograms, and associations with MFI-20 scores were analyzed.
RESULTS: Maximum dose (Dmax) to the brainstem and medulla was significantly associated with MFI-20 scores at 6th week of RT and 1-month post-RT time points, after controlling for baseline scores (p<0.05). Each 1Gy increase in medulla Dmax resulted in an increase in total MFI-20 score over baseline of 0.30 (p=0.026), and 0.25 (p=0.037), at the 6th week of RT and 1-month post-RT, respectively. Each 1Gy increase in brainstem Dmax resulted in an increase in total MFI-20 score over baseline of 0.30 (p=0.027), and 0.25 (p=0.037) at the 6th week of RT, 1-month post-RT, respectively. Statistically significant associations were not found between dosimetry for the other CNS structures and MFI-20 scores.
CONCLUSIONS: In this analysis of PRO fatigue scores from a population of patients undergoing definitive RT for HNC, maximum dose to the brainstem and medulla was associated with a significantly increased risk of acute patient fatigue.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain dose; Fatigue; Head and neck cancer; Quality of life; Radiation therapy

Mesh:

Year:  2017        PMID: 28826628      PMCID: PMC5841457          DOI: 10.1016/j.radonc.2017.08.008

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  45 in total

1.  Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.

Authors:  Martina E Schmidt; Jenny Chang-Claude; Alina Vrieling; Judith Heinz; Dieter Flesch-Janys; Karen Steindorf
Journal:  J Cancer Surviv       Date:  2011-12-11       Impact factor: 4.442

Review 2.  Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards.

Authors:  Charles S Cleeland; Jeff A Sloan
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

3.  Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: a BOLD fMRI study of verbal working memory.

Authors:  G Lange; J Steffener; D B Cook; B M Bly; C Christodoulou; W-C Liu; J Deluca; B H Natelson
Journal:  Neuroimage       Date:  2005-04-07       Impact factor: 6.556

Review 4.  Functional neuroimaging of fatigue.

Authors:  John DeLuca; Helen M Genova; Emlyn J Capili; Glenn R Wylie
Journal:  Phys Med Rehabil Clin N Am       Date:  2009-05       Impact factor: 1.784

5.  Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI)

Authors:  A Trotti; D J Johnson; C Gwede; L Casey; B Sauder; A Cantor; J Pearlman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-09-01       Impact factor: 7.038

6.  High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study.

Authors:  G Brandon Gunn; Tito R Mendoza; Clifton D Fuller; Ibrahima Gning; Steven J Frank; Beth M Beadle; Ehab Y Hanna; Charles Lu; Charles S Cleeland; David I Rosenthal
Journal:  Head Neck       Date:  2012-11-20       Impact factor: 3.147

7.  Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.

Authors:  David I Rosenthal; Tito R Mendoza; Mark S Chambers; Joshua A Asper; Ibrahima Gning; Merrill S Kies; Randal S Weber; Jan S Lewin; Adam S Garden; K Kian Ang; Xin S Wang; Charles S Cleeland
Journal:  Head Neck       Date:  2007-10       Impact factor: 3.147

8.  Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.

Authors:  Hee Chul Park; Nora A Janjan; Tito R Mendoza; Edward H Lin; Saroj Vadhan-Raj; Mandeep Hundal; Yiqun Zhang; Marc E Delclos; Christopher H Crane; Prajnan Das; Xin Shelley Wang; Charles S Cleeland; Sunil Krishnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-21       Impact factor: 7.038

9.  Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome.

Authors:  Karen B Schmaling; David H Lewis; Jessica I Fiedelak; Roderick Mahurin; Dedra S Buchwald
Journal:  Psychosom Med       Date:  2003 Jan-Feb       Impact factor: 4.312

Review 10.  Fatigue in neurological disorders.

Authors:  Abhijit Chaudhuri; Peter O Behan
Journal:  Lancet       Date:  2004-03-20       Impact factor: 79.321

View more
  8 in total

1.  Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating.

Authors: 
Journal:  Radiother Oncol       Date:  2019-01-14       Impact factor: 6.280

2.  Neuromuscular function and fatigability in people diagnosed with head and neck cancer before versus after treatment.

Authors:  Colin Lavigne; Harold Lau; George Francis; S Nicole Culos-Reed; Guillaume Y Millet; Rosie Twomey
Journal:  Eur J Appl Physiol       Date:  2020-04-06       Impact factor: 3.078

3.  Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.

Authors:  Puja Aggarwal; Katherine A Hutcheson; Ryan P Goepfert; Adam S Garden; Naveen Garg; Frank E Mott; Clifton D Fuller; Stephen Y Lai; Gary Brandon Gunn; Mark S Chambers; Ehab Y Hanna; Erich M Sturgis; Sanjay Shete
Journal:  Head Neck       Date:  2022-01-27       Impact factor: 3.147

4.  Proton therapy for newly diagnosed glioblastoma: more room for investigation.

Authors:  Robert H Press; Arpit M Chhabra; J Isabelle Choi; Shaakir Hasan; Madhur Garg; Sonam Sharma; Stanislav Lazarev; T Jonathan Yang; Josh Yamada; Charles B Simone
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

5.  Fatigue in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Prospective Study of Patient-Reported Outcomes and Their Association With Radiation Dose to the Cerebellum.

Authors:  Edvard Abel; Ewa Silander; Fredrik Nordström; Caroline Olsson; N Patrik Brodin; Jan Nyman; Thomas Björk-Eriksson; Eva Hammerlid
Journal:  Adv Radiat Oncol       Date:  2022-04-08

6.  Doc, I feel tired… oh really, so how's your mucositis?

Authors:  Kord M Kober; Sue S Yom
Journal:  Cancer       Date:  2021-05-24       Impact factor: 6.921

7.  Evaluation of auto-planning in VMAT for locally advanced nasopharyngeal carcinoma.

Authors:  Chen Jihong; Chen Kaiqiang; Dai Yitao; Zhang Xiuchun; Chen Yanyu; Bai Penggang
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

8.  Determining Clinical Patient Selection Guidelines for Head and Neck Adaptive Radiation Therapy Using Random Forest Modelling and a Novel Simplification Heuristic.

Authors:  Sarah Weppler; Harvey Quon; Colleen Schinkel; James Ddamba; Nabhya Harjai; Clarisse Vigal; Craig A Beers; Lukas Van Dyke; Wendy Smith
Journal:  Front Oncol       Date:  2021-06-07       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.